secwatch.observer — SEC 8-K summary
======================================

Issuer:     PFIZER INC (PFE)
CIK:        0000078003
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0001193125-23-149364
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pfizer completes $31B multi-tranche note offering to fund Seagen acquisition
----------------------------------------------------------------------------

- Issued $31B aggregate principal across 8 tranches: 2025-2063 maturities, rates 4.45%-5.34%.
- Notes fully and unconditionally guaranteed by Pfizer on a senior unsecured basis.
- Special mandatory redemption at 101% if Seagen merger not consummated by Sep 19, 2024 or abandoned.
- Net proceeds to finance portion of Seagen deal consideration and related fees; proceeds of 2033/2053 notes for general corporate purposes if redemption triggered.
- Issued by wholly-owned Singapore subsidiary Pfizer Investment Enterprises Pte. Ltd.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/78003/000119312523149364/0001193125-23-149364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/78003/000119312523149364/d414076d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-149364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer